Foresight in clinical proteomics: current status, ethical considerations, and future perspectives

With the advent of robust and high-throughput mass spectrometric technologies and bioinformatics tools to analyze large data sets, proteomics has penetrated broadly into basic and translational life sciences research. More than 95% of FDA-approved drugs currently target proteins, and most diagnostic...

Descripción completa

Detalles Bibliográficos
Autores principales: Mundt, Filip, Albrechtsen, Nicolai J. Wewer, Mann, Sebastian Porsdam, Treit, Peter, Ghodgaonkar-Steger, Medini, O’Flaherty, Martina, Raijmakers, Reinout, Vizcaíno, Juan Antonio, Heck, Albert J.R., Mann, Matthias
Formato: Online Artículo Texto
Lenguaje:English
Publicado: F1000 Research Limited 2023
Materias:
Open Letter
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10446044/
https://www.ncbi.nlm.nih.gov/pubmed/37645494
http://dx.doi.org/10.12688/openreseurope.15810.2

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10446044/
https://www.ncbi.nlm.nih.gov/pubmed/37645494
http://dx.doi.org/10.12688/openreseurope.15810.2

Ejemplares similares